Surgical Approach in Liver Hemangiomas
1 other identifier
observational
69
1 country
1
Brief Summary
Operations performed for liver hemangioma between January 2017 and December 2018 will be retrospectively analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2020
CompletedFirst Submitted
Initial submission to the registry
December 2, 2020
CompletedFirst Posted
Study publicly available on registry
December 16, 2020
CompletedDecember 16, 2020
December 1, 2020
19 days
December 2, 2020
December 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complications
Complications after surgery for hemangioma will be collected from records and and will be classified according to 'The Clavien-Dindo Classification of Surgical Complications'. The classification grades are ranging between Grade 1(better) which indicates minor deviation from normal postoperative course and Grade 5 (worst) which means death as a complication.
Complications reported within 3 months after surgery will be evaluated within 15 days after completion of data collection
Secondary Outcomes (2)
Hospital stay
Hospital stay starting with operation and ends with discharge will be compared within 15 days after completion of data collection
Transfusion
Erythrocyte transfusion during surgery will be analyzed within 15 days after completion of data collection
Interventions
Operations in which the hemangioma is selectively removed from the liver parenchyma border are named enucleation, and the operations in which the hemangioma is removed anatomically or non-anatomically with some liver parenchyma surrounding it are named liver resection
Eligibility Criteria
Patients underwent surgery for liver hemangioma between 2007 and 2018 at Ankara University Hospitals
You may qualify if:
- Patients underwent surgery for liver hemangioma
You may not qualify if:
- Cases lacking of more than 20% of critical data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara University Ibni Sina Hospital
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
December 2, 2020
First Posted
December 16, 2020
Study Start
October 1, 2020
Primary Completion
October 20, 2020
Study Completion
October 30, 2020
Last Updated
December 16, 2020
Record last verified: 2020-12